Glycemic control after initiating direct-acting antiviral agents in patients with hepatitis C virus and type 2 diabetes mellitus using the united states integrated healthcare system
Glycemic control after initiating direct-acting antiviral agents in patients with hepatitis C virus and type 2 diabetes mellitus using the united states integrated healthcare system

Alicia Halim Wong; John Sie; Angela Chen; Basuki Gunawan; Joanie Chung; Nazia Rashid

Volume 9, Issue 1 , January 2020, , Pages 16-23

Abstract
   Hepatitis C virus (HCV) has an increased risk of Type 2 diabetes mellitus (T2DM). Prior studies found that the eradication of HCV with direct-acting antiviral (DAA) agents led ...  Read More
Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients

Mansour Siavash; Majid Tabbakhian; Ali Mohammad Sabzghabaee; Niloufar Razavi

Volume 6, Issue 2 , April 2017, , Pages 73-76

Abstract
  This study was designed to compare the severity of gastrointestinal (GI) side effects in Type 2 diabetes mellitus (DM) patients receiving tablet or capsule forms of metformin. Methods: In ...  Read More